- Visibility 262 Views
- Downloads 359 Downloads
- Permissions
- DOI 10.18231/j.ijmmtd.v.11.i.3.23
-
CrossMark
The hidden intruder pulmonary tuberculosis masquerading in interstitial lung disease: A case series
- Author Details:
-
Keerthana Priya
-
Elen Ann Abraham
-
Ghanshyam Verma
-
Akhilanand PG
-
Pedada Mounika
Elen Ann Abraham
Parenchymal lung diseases, such as interstitial lung disease (ILD), may increase the risk of developing pulmonary tuberculosis (TB). Difficulty lies in detecting pulmonary tuberculosis in such patients due to the underlying fibrosis which mask the infection. Many individuals with undiagnosed active or latent do exist since approximately one-third of the world’s population having been exposed to mycobacterium tuberculosis (MTB). We report case series of interstitial lung disease (ILD) with concomitant, microbiologically confirmed pulmonary tuberculosis. This highlights the importance of thorough history taking and clinical evaluation to avoid misdiagnosis and ensure appropriate management.
References
- Wong C, Sahni S, Cheema MAI, Iftikhar A. Mycobacterium tuberculosis Infection in the Setting of Interstitial Lung Disease: Coincidence or Bad Luck? Cureus. 2018;10(10):e3391.
- Akhter N, Rizvi NA. Interstitial Lung Diseases Misdiagnosed as Tuberculosis. Pak J Med Sci. 2018;34(2):338–41.
- Kaur, Harveen; Singh, Dilbag; Pandhi, Naveen. Co-Existence of Pulmonary Tuberculosis with Sarcoidosis. Int J Mycobacteriol. 2021;10(3):341–3.
- Saleem A, Saleem H, Sheikh SS, Akram S, Ali S, Maqsood S. Atypical Imaging Features of Tuberculosis on Computed Tomography That Presented as a Diagnostic Dilemma and To Suggest Possible Factors Responsible for the Unusual Presentation. Pak J Med Health Sci. 2021;14(4):1912–7.
- Khanduri RS, Mason A, Jethani V, Aggarwal A, Khanduri S, Kumar M. Can it be tuberculosis? A case series of atypical presentation of pulmonary tuberculosis. Int J Res Med Sci. 2025;13(4):1641–5.
- Yadav S, Rawal G. Understanding the Spectrum and Management of Post-Tuberculosis Lung Disease: A Comprehensive Review. Cureus. 2024;16(6):e63420.
- Dheda K, Barry CE, Maartens G. Tuberculosis. Lancet. 2016;387(10024):1211–26.
- Thakur S, Chakraborty DS, Lahiry S, Choudhury S. Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario. Lung India. 2020;37(1):77–8.
- Isah MD, Abbas A, Abba AA, Umar M. Idiopathic pulmonary fibrosis misdiagnosed as sputum-negative pulmonary tuberculosis. Ann Afr Med. 2016;15(4):204–6.
- Akhter N, Rizvi NA. Interstitial Lung Diseases Misdiagnosed as Tuberculosis. Pak J Med Sci. 2018;34(2):338–41.
- Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005–15.
- Khalil KF, Butt T. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis. J Coll Physicians Surg Pak. 2015;25(2):115–8.
- Kim EJ, Kim KC, Kim DJ, Park JS. Clinical characteristics and outcomes of tuberculosis in patients with idiopathic pulmonary fibrosis. Respirology. 2016;21(5):823–9.
- Sharma SK, Mohan A, Kadhiravan T. (2015). HIV-TB co-infection: Epidemiology, diagnosis & management. Indian J Med Res. 2005;121(4):550–67.